-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although screening and vaccination in developed countries have greatly reduced the incidence of cervical cancer (CC), this malignant tumor is still a major social burden.
The treatment of early CC (ECC) screening is mainly radical hysterectomy (RH) and pelvic lymph node dissection accompanied by sentinel lymph node biopsy (SLN).
A combination of intermediate risk factors (lymphatic vessel space invasion LVSI, stromal invasion depth DSI, and tumor diameter) or higher risk factors (metastatic lymph node metastasis, parauterine involvement, surgical margin invasion) based on histological records (also called Sedlis standard) can be used for adjuvant treatment of ECC.
A combination of intermediate risk factors (lymphatic vessel space invasion LVSI, stromal invasion depth DSI, and tumor diameter) or higher risk factors (metastatic lymph node metastasis, parauterine involvement, surgical margin invasion) based on histological records (also called Sedlis standard) can be used for adjuvant treatment of ECC.
Therefore, this study aims to evaluate the prognostic value of TFD in early cervical cancer.
This study aims to evaluate the prognostic value of TFD in early cervical cancer.
Distribution of patients based on risk factors
Distribution of patients based on risk factorsThe study included information on 395 patients.
According to the patient survival curve of TFD
According to the patient survival curve of TFDAll in all, the results of the study revealed that pathological TFD≤3.
The results of the study revealed that pathological TFD≤3.
org/10.
Leave a message here